安捷伦科技股价近期疲软，是否该重新评估其投资价值？
Is It Time To Reassess Agilent Technologies (A) After Recent Share Price Weakness - Yahoo Finance
生命科学资讯
生物技术与制药领域的最新动态
安捷伦(A)第四季度财报预期展望 - Finviz
What To Expect From Agilent's (A) Q4 Earnings - Finviz
安捷伦将参加TD Cowen第46届年度医疗保健大会 - 新闻快讯
Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference - News-Press NOW
安捷伦首席财务官参与TD Cowen第46届医疗保健会议讨论 - Stock Titan
Agilent CFO joins TD Cowen’s 46th Health Care Conference chat - Stock Titan
安捷伦将参加TD Cowen第46届年度医疗保健大会 - 商业资讯
Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference - Business Wire
FDA批准强化安捷伦在KEYTRUDA卵巢癌检测中的角色 - simplywall.st
FDA Approval Deepens Agilent Role In KEYTRUDA Ovarian Cancer Testing - simplywall.st
安捷伦科技(A)股票分析：医疗保健领域有望实现38%上涨空间 - DirectorsTalk专访
Agilent Technologies (A) Stock Analysis: A Promising 38% Upside In The Healthcare Sector - DirectorsTalk Interviews
微流控技术研究报告2026-2035：市场规模达207.3亿美元 - 全球新闻通讯社
Microfluidics Research Report 2026-2035: A $20.73 Billion - GlobeNewswire
微流控研究报告2026-2035：2030年市场规模将达207.3亿美元，赛默飞世尔、珀金埃尔默、Dolomite、安捷伦、Bio-Rad与Fluidigm领跑市场——雅虎财经
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading - Yahoo Finance
借助安捷伦（A）第一季度财报抢占先机：华尔街对关键指标的专业解读 - 雅虎财经
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
借助安捷伦(A)第一季度财报保持领先：华尔街对关键指标的深入解读 - 纳斯达克
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics - Nasdaq
安捷伦科技股票：分析师预估与评级 - Barchart.com
Agilent Technologies Stock: Analyst Estimates & Ratings - Barchart.com
安捷伦科技股票：分析师预估与评级 - 雅虎财经
Agilent Technologies Stock: Analyst Estimates & Ratings - Yahoo Finance
安捷伦科技股票：专家预测与评估 - Bitget
Agilent Technologies Shares: Expert Predictions and Evaluations - Bitget
Ventana伴随诊断市场即将迎来繁荣期 | 安捷伦科技 - openPR.com
Ventana Companion Diagnostics Market is Going to Boom | Agilent - openPR.com
安捷伦科技（A）在FDA扩大Keytruda伴随诊断范围后的估值审视——simplywall.st
Agilent Technologies (A) Valuation Check After FDA Expansion Of Keytruda Companion Diagnostic - simplywall.st
安捷伦科技（A）股票分析：为投资者揭示34.86%的潜在上涨空间——DirectorsTalk访谈
Agilent Technologies (A) Stock Analysis: Unpacking A 34.86% Potential Upside For Investors - DirectorsTalk Interviews
安捷伦科技股票：静默上涨，棘手问题——实验室巨头在C轮融资后是否仍值得买入？
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
安捷伦科技(A)的看涨前景可能因新PD-L1测试获批及股息消息而改变 - simplywall.st
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
安捷伦科技公司$A股被荷兰国际集团减持 - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat